Skip to content

The effectiveness of propranolol in difficult to control blood pressure - a randomized trial

Addition of Propranolol in Resistant Arterial Hypertension Treatment - A randomized clinical trial

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
SLCTR
Registry ID
SLCTR/2016/002
Enrollment
120
Registered
2016-01-27
Start date
2016-02-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Resistant hypertension

Interventions

The study will be carried out at medical clinics of the National Hospital of Sri Lanka. Consenting patients meeting inclusion/exclusion criteria will be randomized into two arms. Intervention arm P

Sponsors

National Research Council, Sri Lanka
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age between 18-75 years 2. Resistant hypertension is defined as casual blood pressure during clinical examination of more than 140/90 mmHg (a mean of the 2nd and 3rd measurements during a single examination, at least 3 min apart) despite treatment with a multidrug combination consisting of a diuretic and ACEI/ARB, centrally acting drug, alpha blocker or calcium channel blocker 3. Blood pressure >140/90mmHg in patients below 60 years and >150/90mmHg if above 60 years

Exclusion criteria

Exclusion criteria: 1. Systolic blood pressure > 220mmHg requiring immediate adjustments to therapy 2. Moderate to severe renal insufficiency (acute or chronic) with glomerular filtration rate of less than 30 ml/min , 3. Active bronchospastic disorders 4. Heart failure class III and IV 5. Severe bradycardia(HR<50bpm) 6. AV block 2 and 3 degrees 7. Women who are lactating or pregnant ( a pregnancy test will be carried out during the initial examination) 8. History of hypersensitivity to any of the drugs under study 9. Current use of beta blockers

Design outcomes

Primary

MeasureTime frame
Blood pressure measured by ABPM (ambulatory blood pressure monitoring) [At baseline and three months ]

Secondary

MeasureTime frame
None [None]

Countries

Sri Lanka

Contacts

Public ContactDr. G.R. Constantine

Consultant Cardiologist and Senior Lecturer in Medicine

grogerconstantine@gmail.comTel: 011 2 695300

Outcome results

None listed

Source: SLCTR (via WHO ICTRP) · Data processed: Aug 9, 2026